Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, you are wrong. Radient's Delaware corporate taxes for 2012 were due March 1, 2014. A Delaware corporation does not become void automatically if taxes are not paid by the due date. The 2012 taxes would be listed as past due until Jan 1, 2014 and then the Corporation would be declared VOID.
I took a photo of the lien notice that was posted on the door, It was for a failure to pay the Orange County business property taxes for 2012.
Underdawg, you are wrong.
Just like the IRS, you do not file and pay 2012 taxes in 2012. They are filed and paid in 2013.
Delaware sends a notice to all Delaware corporations in December stating that taxes and an annual report will be due the following march 31.
Radient NEVER completed nor filed an annual report for 2012 nor did they pay the 2012 taxes due March 31, 2013. It is the lack of tax payments that led to becoming a void corporation. When the 2012 taxes were not paid by the end of 2013, Radient's status became VOID.
As for AMDL, Radient had paid some advanced taxes because the amount of tax due for 2013 had a credit of $50. That means the taxes were paid for 2012 from the previously deposited amount but it does not mean that an annual report was filed. We don't have that information. We do know that the 2013 taxes have not been paid and if not paid by the end of 2014, AMDL will become a VOID corporation.
A fast talking con man can take advantage of a lot of people. I look back on this and everything was there to see. The company was set up as a scam by Wittenberg and his group of 52. I was naïve to think that Moro was an innocent victim of the initial scam. He agreed to it all. The rumor from Abbott was that he faked the data on prostate cancer. Obviously Frost got caught up believing in RECAF and that led to more people getting hurt.
At least he is no longer going to ISOBM medical meetings with real researchers and is no longer on their board. Unfortunately, he walked with a lot of investor money via the rebates from Revenue Canada. We can thank Richard Smithline for finally driving the last nail in the biocurex coffin. Smithline could have taken Moro's offer and sold shares to cover some of his losses but Smithline didn't want any more people hurt. He wanted the scam to end. Thank you Richard Smithline.
As most of you know, Moro thought I was his worst enemy but in reality, the truth was his worst enemy.
For anyone who still owned shares of BioCurex on the date of the revocation, you can now deduct those losses on your 2014 tax return. You can deduct your losses on the shares you held on that day. If you are ever audited about the write off, just be sure to present a copy of the SEC final notice of revocation. That should be clear proof it was a worthless stock.
http://www.sec.gov/litigation/admin/2014/34-73872.pdf
Underdawg stated: "Mac has spent a good deal of his life re-organizing AMDL/Radient and developing a successful cancer test and diagnostics concern"
Really? Wow, you have re-written history. Mac took over in 2009 and totally destroyed the company in two years and finally bailed from the ashes in 2014. Well done Mac.
It's all over. The scam is dead.
Final Decision REVOKED
UNITED STATES OF AMERICA
before the
SECURITIES AND EXCHANGE COMMISSION
SECURITIES EXCHANGE ACT OF 1934
Release No. 73872 / December 18, 2014
Admin. Proc. File No. 3-16052
In the Matter of
ASIA CORK, INC.,
BIOCUREX, INC.,
CURRENT TECHNOLOGY CORP.,
GLOBETECH VENTURES CORP., and
PEPPER ROCK RESOURCES CORP.
NOTICE THAT INITIAL DECISION HAS BECOME FINAL
The time for filing a petition for review of the initial decision in this proceeding has
expired. No such petition has been filed by Asia Cork, Inc., Biocurex, Inc., Current Technology
Corp., Globetech Ventures Corp., or Pepper Rock Resources Corp. and the Commission has not
chosen to review the decision on its own initiative.
Accordingly, notice is hereby given, pursuant to Rule 360(d) of the Commission's Rules
of Practice,1 that the initial decision of the administrative law judge2 has become the final
decision of the Commission with respect to Asia Cork, Inc., Biocurex, Inc., Current Technology
Corp., Globetech Ventures Corp., and Pepper Rock Resources Corp. The order contained in that
1 17 C.F.R. § 201.360(d).
2 Asia Cork, Inc., Biocurex, Inc., Carthew Bay Technologies, Inc., Current Tech. Corp.,
Gamecorp Ltd. (n/k/a DealNet Capital Corp.), Globetech Ventures Corp., and Pepper Rock Res.
Corp., Initial Decision Rel. No. 686 (Oct. 7, 2014), 109 SEC Docket 19, 2014 WL 4980875.
The stock symbols and Central Index Key numbers are: AKRK and 1104040 for Asia Cork, Inc.;
BOCX and 1092562 for Biocurex, Inc.; CRTCF and 883907 for Current Technology Corp.;
GTVCF and 947994 for Globetech Ventures Corp.; and PEPR and 1448242 for Pepper Rock
Resources Corp.
2
decision is hereby declared effective. The initial decision ordered that, pursuant to Section 12(j)
of the Securities Exchange Act of 1934, the registrations of each class of registered securities of
Asia Cork, Inc., Biocurex, Inc., Current Technology Corp., Globetech Ventures Corp., and
Pepper Rock Resources Corp. are hereby revoked.
For the Commission, by the Office of the General Counsel, pursuant to delegated
authority.
Brent J. Fields
Secretary
All anyone has to do is run the sere numbers for incidents of lung cancer and immediately, it is evident that the false positives are way too high for WG's best to be used as a screener. What WG really wants is a salary from investor money as long as it will last.
If he had something new with a patent, he might get investor money but a 30 year old technology with no patent is just not going to work.
IMO, you are correct about the "perks". They apparently will evaporate if the funding goal is not met.
It just looks too much like a scam to raise money. His problem is that he is not willing to put his own money at risk. If he really believed in it, it might make a difference.
At least Reese was smart enough to realize it was not worth investing their money and he dumped it.
DR70 has been approved by Health Canada for lung cancer for over 10 years and yet, no distributors nor sales.
Underdawg, Delaware corporation franchise taxes are due 1 March and are late after 1 Jume. Radient has NOT paid the 2014 taxes nor have they filed an annual report for 2013 or 2012.
Radient is in Bad Standing in Delaware. The corporation will become VOID after 1 Jan 2015.
Dcspka stated: "Here is where I am confused."
Apparently, confusion appears to be a continued state of mind. None of your posts make any sense at all.
Living, Mac defaulted on the new loan right after the SEC denied his filing for a quickie S-3 registration. The SEC originally accepted that S-3 filing made shortly after the loan. I had a valid email address of the corporate division and I sent them information that disqualified Radient from using an S-3. The SEC in turn, then send Mac a notice that an extensive S-1 would be required. He then defaulted because he would never get an S-1 approved without a huge delay. Mac was using the loan to fund the payments to the lenders. Sorry about that but the law is the law and I would not let Mac get away with it.
Underdawg stated: "The reason radient is being the target is DR-70
"
Why would anyone want the DR70 trademark? That is all that Radient has remaining. There is no product now because the FDP test called DR70 is now in the public domain. No one owns it and it can be used by anyone with no royalties involved.
Radient is no longer getting any royalties from anyone.
"The dtectDx™ Breast Serum Biomarker Test
The dtectDx™ Breast (Provista Diagnostics) serum biomarker test
analyzes concentrations of five serum biomarkers: IL-8, IL-12, VEGF, CEA, and HGF via ELISA (see Figure 3). These data are combined with select patient characteristics in an algorithm that generates a value of normal or elevated risk."
That's it. Your dream is over. DR70 is not used by Provista in their breast cancer test as you have been claiming.
Underdawg, the Delaware site also shows a $200 fee due for 2014 and that will not be paid. In another month, AMDL Diagnostics will be a void corporation also. The only reason it is not void today is that several years ago, Radient placed money in the account to pay future fees. That money has now been used.
When AMDL Diagnostics goes to void status in 2015, what will be your explanation for that?
The article points out two huge problems with the test.
"When he was trying to market the breast cancer blood test, one of the barriers to its success was working with insurance carriers. He's learned his lesson and won't bother trying to get the test covered by health insurance companies.
Instead, he is selling the blood test directly to consumers for $99."
Insurance is the biggest problem for any drug or medical device. People will just not pay for the test out of pocket. It is not approved and doctors will not recommend it nor utilize the results.
"It will be sold directly to consumers in the 26 states that allow that, where consumers can go online on our website and order the test," he said. Consumers will get an insulated box in the mail, which will be used to ship the blood to its Phoenix lab for testing."
The blood sample needs to be centrifuged and shipped to PHX by the draw lab. It is mandatory that it be refrigerated and should use dry ice. The sample will quickly deteriorate if not maintained cooled and ice packs may not be enough. The insulated containers are not cheap and Gartner will probably attempt to recycle them to other customers if he ever makes any sales.
Searching for investors has obviously failed. Gartner is now asking for donations to fund the purchase of mailing lists of smokers and former smokers. He is also appealing to families of smokers.
He has also reduced the price of the test. If this fails to produce any sales, it is probably the death of GCDX.
"Our goal is to spread the word about the test to as many people as possible and to allow you to purchase the test for yourself, your family or friends at a lower cost than is now available. Our price on The Lung Cancer Test is only $99 plus shipping and handling. However, during the crowdfunding campaign we have lowered this to $75 plus S&H and packaged two tests at only $125 plus S&H."
https://www.indiegogo.com/projects/save-a-life-with-the-lung-cancer-test
Don't burn them. Send them to Underdawg. He can pass them out to his relatives and claim Radient paid stock dividends this year.
Most scam companies set up Nevada public corporations. Nevada has minimal requirements to operate a corporation. Not saying all Nevada corporations are scams but it is the easiest to use.
Living, yes, the sun is nice for a while. We are building a house and just got is stucco wrapped in time for the rain this week.
DC and Underdawg just keep droning on about Radient coming back from the dead. It's absurd how they think DR70 has value when it is off patent. The trademarks of DR70 and Onko Sure are still live but anyone can call it the "dog poop test" and it would be legal to sell. Problem is, no one wants the test. CIT is dead so there is nothing left.
I would guess the Aussies took what they could and that's that.
I will stop by the old Radient office next time I go North and see if the office condo has any new tenants yet.
Those who owned Radient shares didn't just shoot themselves in the foot, they took a hit in their wallet as well.
The postings cannot get any more ridiculous than a three way merger but go for a five or six way.
Radient will be the same dead company next year as they are now. The Aussies took whatever they wanted to never be heard from again.
Underdawg stated: "Seattle Area..That is where Radients Patent attorney firm is located you understand..."
Did you forget that Radients patent attorney resigned. Radient has no patent attorney and the patent office has no contact number or address for Radient.
Underdawg, you are obviously not at all familiar with what went on between jade and amdl.
Mac began to sell off jade assets and that is when the Chinese went ballistic and rebelled. Comments on this forum should have a factual basis and not just fantasies.
DC, you are wrong again. Why would you claim that Provistadx is a Nevada corporation?
http://starpas.azcc.gov/scripts/cgiip.exe/WService=wsbroker1/names-detail.p?name-id=F17887633&type=CORPORATION
Even though AMDL got FDA clearance for DR70, the product never got the AMA to give it a coding. If Underdawg and DC would actually read the FDA clearance letter, they would see that DR70 was to be used in conjunction WITH CEA. It was not cleared to replace CEA, it was an added test and no one is going to approve payment for an added test that does not give added value.
That is why DR70 failed. Dreyer realized this and that is why he wanted to spin off DR70 and be done with it. AMDL had spent too much money on it already and it was going to fail even after FDA clearance and fail it did.
Underdawg, if you actually read the SEC filings, you will see that the former CEO, Gary L. Dreher, did as much as he could to make AMDL a success as a Chinese Pharma. Dreher's plan was to spin off DR70 into a separate division to sell and totally convert the company to a Chinese pharma.
Dreher was forced out by Mac who promptly angered the Chinese and it went all downhill from there. Dreher got money from new investors where Mac resorted to loans from hedge funds who had little interest in the future of the company.
Mac was the idiot here, not Dreher. At least Dreher knew that the future of the company was not going to be with DR70.
Jim, I have mentioned before how researchers do a lot of "busywork" that really is not useful. What is anyone going to do with a test that is around 75% sensitivity and specificity?
Do you know what those numbers mean? It cannot be used for screening. Just run the numbers. The incidence of lung cancer is less than .5% so in a thousand people, you would only expect to have 5 people actually having lung cancer. The test has a sensitivity of 75% so you would only find less than 4 of those cancers but the huge problem is 25% of those 1000 persons would have false positives. That is 250 FALSE POSITIVES.
What do you tell that 250 people? "You may have cancer"? What do you tell the 4 persons you actually found? "You may have cancer"?
It's worthless Jim. I worked for professors who actually published studies. It is just a numbers game. X number of published papers give them status in their world.
Can you understand why DR70 never went anywhere in the medical world?
Now if you restrict your screening to those over 50 and smokers, the cancer rate is much higher and you get a slightly higher number of false positives as you do actual cancers. It is still iffy as a screen though. I've run the numbers on Gartners test and he would still not get FDA approval for screening and probably only get approval if lung cancer was diagnosed first via some other method before a test could be given.
The above is just reality. Believe what you like but the above is absolutely true.
Jim, The Koreans doing the research are not trying to sell DR70. They can call it anything they like and not violate any trademarks. You only violate trademarks if you attempt to sell a product under the name DR70.
There is no combination test using DR70. That is just a fabricated story by Woofie the UnderDawg.
I would agree that UNI Pharma may be is some sort of trademark violation by selling their off patent DR70 under that name and Onko sure. But tell me who is going to sue them? No one. Radient is gone and controlled by the invisible Aussies.
Jim, do you not understand what a patent life span is? In most cases, it is 20 years. DR70 is OFF PATENT. Anyone can make it or use it without any royalties to Radient. It has no value at all to Radient. Under your assumption, the Edison estate would still be receiving royalties for every light bulb ever made.
Jim stated: "That's the million dollar question. How will shareholders benefit?"
That certainly is not a million dollar question. It is hardly worthy of any comments because the shares are worthless. Everything claimed to be positive regarding the stock are just lies.
It has now been 7 1/2 months and not one peep has been heard from Radient. I have already proclaimed it totally dead. The question now is when you will agree that Radient is dead? Another month? Another year? Another decade? How long can lies attempt to support a dead and gone company?
At this point, one wonders why the creators of the "merger rumor" continue to adapt their "merger theory" even as all valid information continues to support the fact that Radient is dead and gone.
Who is the fantasy meant to fool?
Is it their friends and relatives who purchased the stock based on their recommendation?
It certainly is not new investors because you cannot buy or sell and Radient shares. The SEC has prohibited any public sale of the shares.
Is the "rumor" just meant to fool its creators into thinking they haven't really lost their money?
And finally, there really isn't any "rumor" at all. It is just a fantasy.
GetSeriousOK wrote:
"Radient can't sue without a patent.
If GCDx had started selling the test before the patent expired, then yes, albet a very small lawsuit, because damages are so minimal. But GCDx waited until the patent expired and the only remaining patent application was rejected.
There are no secret agreements or diversions or creeping mergers. What we see is what is happening: GCDx is trying to sell the test and Radient is dead. Nothing is hidden here.
The merger rumor started in March 2011 and continues today only because a couple of "Longs" refuse to admit purchasing Radient shares was a bad investment."
Underdawg, Gartner is not selling DR70. He is selling "The Lung Cancer Test". The test for FDP is now off patent and anyone can use it. There is no copyright violation because Gartner never calls any portion of his test "DR70".
Gartner did indeed outsmart Mac and got everything he wanted from Radient for only $6,000.
UNI Pharma got everything they wanted from Mac also. They no longer have to pay royalties and their deal is cancelled. They don't worry about copyrights because who is going to sue them? Wolfie and DC?
If there was still some kind of deal or possibility involving Radient and someone else, Mac would never have bailed.
The only reason Mac left was because Radient no longer had anything of value anyone would be interested in.
One of the later 8K's cancelled the agreement with GCDX. There is no agreement at that point so how can you sue?
Underdawg, you have it all wrong again.
The license of LymPro has nothing to do with Radient or Provistadx.
That is a FACT.
This is a history of events.
Provista Life Sciences signed an agreement to investigate a merger possibility with Radient.
That agreement died from lack of action by Provista Life Sciences.
William Gartner controlled Provista Life Sciences.
Gartner sold all of the women's health diagnostics to Provistadx.
Gartner then changed the name of Provista Life Sciences to Memorydx. (that is factual. Check corp filing in AZ)
Memorydx then licensed LymPro.
Gartner formed a new corporation, GCDX.
GCDX then attempted to license DR70 for lung cancer use. That attempt failed because Gartner elected to not pay the license fee even after all the data on how to make DR70 kits was transferred to GCDX.
Gartner can now manufacture and sell Fribrin degradation kits royalty free because DR70 patents have expired.
Radient has no connection whatsoever with any of the corporations above.
Sunnybank, you can answer some of those questions by doing a little work on your own.
Just do some searches on who is a reverse merger candidate. For one, they need to be public and they need to be trading. Radient is neither. Any debt they have needs to be eliminated. If you look at the contract of the last lenders, by agreement, their debt and any stock they hold flows through bankruptcy. No one wanting to reverse merge would want to be dealing with a lot of debt.
Secondly, if Mac thought there was any potential of Radient making any money or a reverse merger occurring, he wouldn't have abandoned the CEO position.
Thirdly, Radient has no product of any value.
There are lots of public corporations out there who would be reverse merger candidates. No one would attempt to use Radient.
DR70 tests for multiple FDP's. d-Dimmer is one of those FDP's and there are commercial tests available just for d-Dimmer. d-Dimmer is an indicator of heart problems and that is one of the problems DR70 has with the number of false positives when used to test for cancer.
DR70 does not break any thing down. It is a combination of antibodies used to test for FDP's. Rather that just posting woofspeak, you should actually read some of the papers written on DR70.
"DR-70 is used to break down other protein based bio markers. This is a proven fact." That's just more "woofspeak".
New woof speak: "Dr-70 is used to break down the proteins in the other 5 protein bio markers as well."
DR70 doesn't break anything down. Fibrin is used in the process of wound healing. As the process is completed, the fibrin degradation products are released into the bloodstream. DR70 tests for the FDP. Again, it does not break proteins down. To claim such is just woofspeak.